A study of susceptibility of 100 clinical isolates belonging to the Streptococcus milleri group to 16 cephalosporins

被引:13
作者
Aracil, B [1 ]
Gomez-Garces, JL [1 ]
Alos, JI [1 ]
机构
[1] Hosp Mostoles, Inst Nacl Salud, Microbiol Serv, Madrid 28935, Spain
关键词
D O I
10.1093/jac/43.3.399
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The Streptococcus milleri group are uniformly susceptible to penicillin G, but their susceptibilities to different cephalosporins vary considerably. The antimicrobial susceptibilities of 100 clinically significant strains of the S. milleri group to 16 cephalosporins were determined by the agar dilution method. The majority of first-generation cephalosporins were highly active. Cefamandole, cefuroxime and cefprozil were the most active second-generation agents examined. Third-generation parenteral cephalosporins exhibited excellent activity, with the exception of ceftazidime. The most active of the oral preparations of this group was cefpodoxime, with cefixime and ceftibuten being considerably less active. MICs of cefepime, the only fourth-generation cephalosporin tested, were higher than those of cefotaxime and ceftriaxone.
引用
收藏
页码:399 / 402
页数:4
相关论文
共 10 条
[1]   IN-VITRO ACTIVITIES OF 22-BETA-LACTAM ANTIBIOTICS AGAINST PENICILLIN-RESISTANT AND PENICILLIN-SUSCEPTIBLE VIRIDANS GROUP STREPTOCOCCI ISOLATED FROM BLOOD [J].
ALCAIDE, F ;
LINARES, J ;
PALLARES, R ;
CARRATALA, J ;
BENITEZ, MA ;
GUDIOL, F ;
MARTIN, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (10) :2243-2247
[2]   Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States [J].
Doern, GV ;
Ferraro, MJ ;
Brueggemann, AB ;
Ruoff, KL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) :891-894
[3]   COMPARISON OF SINGLE DOSES OF AMOXICILLIN OR OF AMOXICILLIN-GENTAMICIN FOR THE PREVENTION OF ENDOCARDITIS CAUSED BY STREPTOCOCCUS-FAECALIS AND BY VIRIDANS STREPTOCOCCI [J].
FRANCIOLI, P ;
MOREILLON, P ;
GLAUSER, MP .
JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (01) :83-89
[4]   BACTERIOLOGICAL CHARACTERISTICS AND ANTIMICROBIAL SUSCEPTIBILITY OF 70 CLINICALLY SIGNIFICANT ISOLATES OF STREPTOCOCCUS-MILLERI GROUP [J].
GOMEZGARCES, JL ;
ALOS, JI ;
COGOLLOS, R .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1994, 19 (02) :69-73
[5]   CONJUGATIVE TRANSFER OF MULTIPLE-ANTIBIOTIC RESISTANCE MARKERS IN BETA-HEMOLYTIC GROUP-A, B, F, AND G STREPTOCOCCI IN THE ABSENCE OF EXTRACHROMOSOMAL DEOXYRIBONUCLEIC-ACID [J].
HORODNICEANU, T ;
BOUGUELERET, L ;
BIETH, G .
PLASMID, 1981, 5 (02) :127-137
[6]  
National Committee for Clinical Laboratory Standards, 1997, M7A4 NCCLS
[7]   STREPTOCOCCUS-MILLERI GROUP - RENEWED INTEREST IN AN ELUSIVE PATHOGEN [J].
PISCITELLI, SC ;
SHWED, J ;
SCHRECKENBERGER, P ;
DANZIGER, LH .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (06) :491-498
[8]   OCCURRENCE AND CULTURAL FEATURES OF STREPTOCOCCUS-MILLERI IN VARIOUS BODY SITES [J].
POOLE, PM ;
WILSON, G .
JOURNAL OF CLINICAL PATHOLOGY, 1979, 32 (08) :764-768
[9]  
RUOFF K L, 1988, Clinical Microbiology Reviews, V1, P102
[10]   EMENDED DESCRIPTIONS AND RECOGNITION OF STREPTOCOCCUS-CONSTELLATUS, STREPTOCOCCUS-INTERMEDIUS, AND STREPTOCOCCUS-ANGINOSUS AS DISTINCT SPECIES [J].
WHILEY, RA ;
BEIGHTON, D .
INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, 1991, 41 (01) :1-5